 Deciphera Pharmaceuticals NASDAQ:DCPH was downgraded by analysts at BidaskClub from a hold rating to a sell rating in a report released on Thursday, BidAskClub reports. Several other brokerages also recently weighed in on DCPH. Nomura downgraded Deciphera Pharmaceuticals from a buy rating to a neutral rating and decreased their target price for the company from ... 